Institutional
TCG Crossover Management, LLC
CIK 0001839948
$3.50B
Reported AUM
49
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · TCG Crossover Management, LLC · Q1 2026
AI · grounded in 13F
TCG Crossover Management, LLC exited its position in RAPT for a reduction of $87.5M. The fund established new positions in BCRX for $104.9M, VOR for $96.5M, and DISC MEDICINE INC for $85.8M. Additionally, the manager closed its position in EYPT for $65.3M and increased its stake in MIRM by 1611.6%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | $721.7M | 20.65% | -630,511 | -8.9% |
| 2 | CGON | CG ONCOLOGY INC | $248.4M | 7.11% | — | HELD |
| 3 | TNGX | TANGO THERAPEUTICS INC | $220.3M | 6.30% | -2,231,023 | -17.5% |
| 4 | COGT | COGENT BIOSCIENCES INC | $190.4M | 5.45% | -921,268 | -15.7% |
| 5 | CNTA | CENTESSA PHARMACEUTICALS PLC | $170.3M | 4.87% | — | HELD |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $140.7M | 4.03% | — | HELD |
| 7 | TYRA | TYRA BIOSCIENCES INC | $124.4M | 3.56% | +350,877 | +12.1% |
| 8 | IMVT | IMMUNOVANT INC | $110.7M | 3.17% | +2,797,055 | +168.4% |
| 9 | BCRX | BIOCRYST PHARMACEUTICALS INC | $104.9M | 3.00% | +11,020,968 | NEW |
| 10 | MIRM | MIRUM PHARMACEUTICALS INC | $98.1M | 2.81% | +1,000,000 | +1611.6% |
| 11 | VOR | VOR BIOPHARMA INC | $96.5M | 2.76% | +5,673,078 | NEW |
| 12 | SYRE | SPYRE THERAPEUTICS INC | $95.9M | 2.74% | — | HELD |
| 13 | AMLX | AMYLYX PHARMACEUTICALS INC | $86.8M | 2.48% | — | HELD |
| 14 | IRON | DISC MEDICINE INC | $85.8M | 2.45% | +1,341,862 | NEW |
| 15 | DYN | DYNE THERAPEUTICS INC | $83.7M | 2.39% | — | HELD |
| 16 | GLUE | MONTE ROSA THERAPEUTICS INC | $76.0M | 2.18% | — | HELD |
| 17 | SVRA | SAVARA INC | $67.5M | 1.93% | — | HELD |
| 18 | RVMD | REVOLUTION MEDICINES INC | $56.1M | 1.60% | +140,000 | +32.1% |
| 19 | KOD | KODIAK SCIENCES INC | $55.1M | 1.58% | — | HELD |
| 20 | LBRX | LB PHARMACEUTICALS INC | $45.3M | 1.30% | +94,474 | +5.4% |
| 21 | SRZN | SURROZEN INC | $42.9M | 1.23% | +1,473,101 | NEW |
| 22 | ADCT | ADC THERAPEUTICS SA | $42.7M | 1.22% | — | HELD |
| 23 | RLAY | RELAY THERAPEUTICS INC | $42.5M | 1.22% | +1,053,170 | +32.7% |
| 24 | FULC | FULCRUM THERAPEUTICS INC | $40.3M | 1.15% | — | HELD |
| 25 | BHVN | BIOHAVEN LTD | $39.2M | 1.12% | — | HELD |
| 26 | IPSC | CENTURY THERAPEUTICS INC | $39.0M | 1.12% | +17,754,430 | NEW |
| 27 | TECX | TECTONIC THERAPEUTIC INC | $37.2M | 1.07% | +1,204,891 | NEW |
| 28 | CATX | PERSPECTIVE THERAPEUTICS INC | $33.0M | 0.94% | +7,915,567 | NEW |
| 29 | XNCR | XENCOR INC | $29.6M | 0.85% | — | HELD |
| 30 | TRDA | ENTRADA THERAPEUTICS INC | $28.9M | 0.83% | +199,108 | +9.5% |
| 31 | ALXO | ALX ONCOLOGY HOLDINGS INC | $26.1M | 0.75% | +13,011,849 | NEW |
| 32 | ARVN | ARVINAS HOLDING CO LLC | $25.3M | 0.72% | -278,755 | -10.5% |
| 33 | JANX | JANUX THERAPEUTICS INC | $24.9M | 0.71% | — | HELD |
| 34 | AGMB | AGOMAB THERAPEUTICS NV | $21.5M | 0.62% | +2,053,233 | NEW |
| 35 | ALEC | ALECTOR INC | $21.5M | 0.62% | — | HELD |
| 36 | MBX | MBX BIOSCIENCES INC | $19.4M | 0.56% | — | HELD |
| 37 | SLN | SILENCE THERAPEUTICS PLC | $16.0M | 0.46% | — | HELD |
| 38 | LQDA | LIQUIDIA TECHNOLOGIES INC | $15.2M | 0.44% | -1,307,036 | -76.4% |
| 39 | OCUL | OCULAR THERAPEUTIX INC | $14.0M | 0.40% | -4,092,479 | -71.3% |
| 40 | AVTX | AVALO THERAPEUTICS INC | $11.0M | 0.32% | +255,383 | +52.9% |
| 41 | URGN | UROGEN PHARMA LTD | $7.3M | 0.21% | -311,982 | -43.5% |
| 42 | MNPR | MONOPAR THERAPEUTICS INC | $7.2M | 0.21% | -9,812 | -6.9% |
| 43 | CNTX | CONTEXT THERAPEUTICS INC | $7.0M | 0.20% | +2,682,696 | NEW |
| 44 | GPCR | STRUCTURE THERAPEUTICS INC | $6.8M | 0.19% | -780,446 | -84.8% |
| 45 | CGEM | CULLINAN THERAPEUTICS INC | $5.8M | 0.17% | +406,786 | NEW |
| 46 | KRRO | KORRO BIO INC | $4.7M | 0.13% | — | HELD |
| 47 | LONA | LEONABIO INC | $4.7M | 0.13% | — | HELD |
| 48 | UPB | UPSTREAM BIO INC | $1.6M | 0.05% | -562,823 | -75.7% |
| 49 | VTGN | VISTAGEN THERAPEUTICS INC | $1.5M | 0.04% | — | HELD |
| 50 | RAPT | RAPT THERAPEUTICS INC | — | — | -2,582,408 | EXITED |
| 51 | EYPT | EYEPOINT PHARMACEUTICALS INC | — | — | -3,572,335 | EXITED |
| 52 | AGIO | AGIOS PHARMACEUTICALS INC | — | — | -1,181,841 | EXITED |
| 53 | MAZE | MAZE THERAPEUTICS INC | — | — | -173,816 | EXITED |
| 54 | VTYXUSD | VENTYX BIOSCIENCES INC | — | — | -316,195 | EXITED |
Source: SEC EDGAR · accession 0001214659-26-006367. 13F discloses long positions only — shorts, foreign equities, and options are excluded.